|Other Names||Uncharacterized protein KIAA0513, KIAA0513|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP13320c was selected from the Center region of KIAA0513. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Tissue Location||Widely expressed, highest levels in cerebellum, brain cortex, hippocampus, pons, putamen and amygdala Highly expressed in neurons, but also present in glial cells Slightly higher expression in the dorsolateral prefrontal cortex of schizophrenic patients compared to control individuals|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The specific function of this protein remains unknown.
Rose, J. Phd, et al. Mol. Med. (2010) In press :Lauriat, T.L., et al. Brain Res. 1121(1):1-11(2006)
If you have any additional inquiries please email technical services at email@example.com.